Cancer Research KI December Newsletter
Research News

December 2020

 

Read the newsletter in your browser

Tell a colleague about this newsletter

Cancer Research KI will have a new elected executive board for 2021!

 

Dear Cancer Research KI community,

 

It is with great pleasure that we announce the newly elected Executive Board that will be starting in 2021, and we welcome all members of the Board.

 

The members for the new Cancer Research KI Executive Board have been proposed after thorough work by the five-member Nomination Committee (elected by the Cancer Research KI Reference Group). The Nomination Committee presented a list with suggestions for the Director, two co-directors, and eight members of the Executive Board. Considerations such as gender, cancer expertise (clinical and pre-clinical), discipline, geography, and career stage were taken into account during the process.

 

The Reference Group then presented the list to the Committee for Research. The Committee for Research approved, on the 18th of November, the suggestion for the new Executive Board from the Nomination Committee. The members in the new Cancer Research KI Executive Board are presented below.

 

Congratulations to the incoming Executive Board, and thank you to all exiting members for their hard work and dedication to Cancer Research KI!

 

Best wishes,

 

Jonas Bergh, Director

Kamila Czene, Co-Director

Urban Lendahl, Co-Director

Elected executive board members

 
 

All the newsletters of 2020, including the recipients of our grant calls as well as our very own Cancer Researcher Portraits can all be found here.

 
 
Facebook Twitter Cancer Research KI Homepage
 

Cancer Research KI is an overarching umbrella organisation and single point of entry to cancer research at Karolinska Institutet, conducted by some 250 research groups at multiple campuses and departments. The aim is to combine cancer research with clinical oncology by bringing together top level cancer scientists from different disciplines, with the overall goal to generate new scientific discoveries that can be rapidly translated into clinical practice for the benefit of patients and society.

Subscribe to our newsletter

 

Click here to unregister your address

Do not click this link

Skickat med Paloma